PRIA Logo™
West VirginiaHB 46262026 Regular SessionHouse

Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine

Sponsored By: Ryan Browning (Republican)

Vetoed

§16-67-1§16-67-2§16-67-3§16-67-4§16-67-5§16-67-6§16-67-7Vetoed

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Ryan Browning

    Republican • House

Cosponsors

  • Adam Burkhammer

    Republican • House

  • Mark Dean

    Republican • House

  • Scot C. Heckert

    Republican • House

  • Rick Hillenbrand

    Republican • House

  • Michael Hite

    Republican • House

  • Evan Worrell

    Republican • House

Roll Call Votes

All Roll Calls

Yes: 130 • No: 0

Senate vote • 3/12/2026

Passed Senate (Roll No. 487)

Yes: 34 • No: 0

House vote • 1/29/2026

Passed House (Roll No. 32)

Yes: 96 • No: 0

Actions Timeline

  1. Vetoed by Governor 4/1/2026

    4/2/2026House

  2. To Governor 3/31/2026

    3/31/2026House

  3. To Governor 3/31/2026 - Senate Journal

    3/14/2026Senate

  4. Vetoed by Governor 4/1/2026 - Senate Journal

    3/14/2026Senate

  5. Vetoed by Governor 4/1/2026 - House Journal

    3/14/2026House

  6. House received Senate message

    3/13/2026House

  7. On 3rd reading

    3/12/2026Senate

  8. Read 3rd time

    3/12/2026Senate

  9. Passed Senate (Roll No. 487)

    3/12/2026Senate

  10. Communicated to House

    3/12/2026Senate

  11. Completed legislative action

    3/12/2026Senate

  12. On 2nd reading

    3/11/2026Senate

  13. Read 2nd time

    3/11/2026Senate

  14. On 1st reading

    3/10/2026Senate

  15. Read 1st time

    3/10/2026Senate

  16. Reported do pass

    3/9/2026Senate

  17. Reported do pass, but first to Finance

    2/18/2026Senate

  18. To Finance

    2/18/2026Senate

  19. Introduced in Senate

    1/30/2026Senate

  20. To Health and Human Resources then Finance

    1/30/2026Senate

  21. To Health and Human Resources

    1/30/2026Senate

  22. On 3rd reading, Special Calendar

    1/29/2026House

  23. Read 3rd time

    1/29/2026House

  24. Passed House (Roll No. 32)

    1/29/2026House

  25. Communicated to Senate

    1/29/2026House

Bill Text

Related Bills

Back to State Legislation